Company: ERAS
Filing Date: 2025-03-20
Form Type: 10-K
Source: 0000950170-25-042682
Chunk: 95

Company: Erasca, Inc.
Filing Date: 2025-03-20
Form: 10-K
Item: Item 8
Chunk 95
---
,619

    3,970

    Total current liabilities

    31,395

    26,156

    Operating lease liabilities, net of current portion

    47,270

    51,889

    Other liabilities

    362

    566

    Total liabilities

    79,027

    78,611

    Commitments and contingencies (Note 12)

    Stockholders' equity:

    Preferred stock, $0.0001 par value; 80,000,000 shares authorized at December 31, 2024 and 2023; no shares issued and outstanding at December 31, 2024 and 2023

    —

    —

    Common stock, $0.0001 par value; 800,000,000 shares authorized at December 31, 2024 and 2023; 283,218,344 shares issued and outstanding at December 31, 2024; 151,462,103 and 151,090,227 shares issued and outstanding at December 31, 2023, respectively

    28

    15

    Additional paid-in capital

    1,190,729

    922,607

    Accumulated other comprehensive income

    405

    77

    Accumulated deficit

    (767,663
    )

    (606,013
    )

    Total stockholders' equity

    423,499

    316,686

    Total liabilities and stockholders' equity
     
    $
    502,526

    $
    395,297

The accompanying notes are an integral part of these consolidated financial statements.

F-3

Erasca, Inc.

Consolidated Statements of Operations and Comprehensive Loss

(In thousands, except share and per share amounts)

    Year Ended December 31,

    2024

    2023

    Operating expenses:

    Research and development
     
    $
    115,359

    $
    103,821

    In-process research and development

    22,500

    —

    General and administrative

    41,728

    37,704

    Total operating expenses

    179,587

    141,525

    Loss from operations

    (179,587
    )

    (141,525
    )

    Other income (expense)

    Interest income